BIZON Labs

The way a drug is made should never limit its potential.

Lipid nanoparticle illustration

Technology

Bizon Labs developed the only technology that precisely tunes lipid nanoparticle critical quality attributes, including particle size and morphology—enabling applications previously out of reach.

Improved in vivo expression

Up to 3× higher in vivo expression enabled by precise control of LNP particle size and morphology (n = 7).

Precise LNP engineering

Any LNP size between 40–450 nm with controlled morphology (bleb fraction) in minutes.

Rapid scale-up

Scale-up from microfluidic mixers to pilot-scale jet mixers in days instead of months.

Access to Predictive Models

Process models that predict development and manufacturing success or failure.

Bizon Labs Team

We are three postdoctoral researchers at the Massachusetts Institute of Technology developing technologies to precisely engineer lipid nanoparticles and accelerate process development for genetic medicines.

Bison are known for moving into storms rather than away from them, reaching safety faster by confronting challenges directly. They also create bison paths that other animals follow, shaping the movement of entire ecosystems.

At Bizon Labs, our goal is to do the same: build new paths for how advanced medicines are developed and manufactured.

Get in touch

Interested in our technology or exploring a collaboration? We'd love to hear from you.